Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review
Peramaiyan Rajendran1,2, Ramya Sekar3,2, Prabhu Shankar Dhayasankar4
1Department of Biological Sciences, College of Science, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.
Abstract:
Oral cancer is the most heterogeneous cancer at clinical and histological levels. PI3K/AKT/mTOR pathway was identified as one of the most commonly modulated signals in oral cancer, which regulates major cellular and metabolic activity of the cell. Thus, various proteins of PI3K/AKT/mTOR pathway were used as therapeutic targets for oral cancer, to design more specific drugs with less off-target toxicity. This review sheds light on the regulation of PI3K/AKT/mTOR, and its role in controlling autophagy and associated apoptosis during the progression and metastasis of oral squamous type of malignancy (OSCC). In addition, we reviewed in detail the upstream activators and the downstream effectors of PI3K/AKT/mTOR signaling as potential therapeutic targets for oral cancer treatment.
Insights
This review explores the PI3K/AKT/mTOR pathway
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Oral cancer exhibits significant clinical and histological heterogeneity.
- The PI3K/AKT/mTOR pathway is frequently dysregulated in oral cancer, controlling vital cellular functions.
- Targeting this pathway offers potential for developing specific oral cancer therapeutics with reduced toxicity.
Purpose of the Study:
- To elucidate the regulation of the PI3K/AKT/mTOR pathway in oral squamous cell carcinoma (OSCC).
- To detail the pathway's role in regulating autophagy and apoptosis during OSCC progression and metastasis.
- To identify upstream activators and downstream effectors of PI3K/AKT/mTOR signaling as therapeutic targets for oral cancer.
Main Methods:
- Literature review focusing on PI3K/AKT/mTOR signaling in oral cancer.
- Analysis of studies investigating pathway regulation, autophagy, and apoptosis.
- Identification of potential therapeutic targets within the PI3K/AKT/mTOR pathway.
Main Results:
- The PI3K/AKT/mTOR pathway is a key regulator of cellular and metabolic activities in oral cancer.
- Dysregulation of this pathway influences autophagy and apoptosis, contributing to OSCC progression and metastasis.
- Specific proteins within the pathway present viable targets for novel oral cancer drug development.
Conclusions:
- The PI3K/AKT/mTOR pathway is a critical determinant in oral squamous cell carcinoma.
- Understanding its regulatory mechanisms and downstream effects is crucial for effective oral cancer treatment strategies.
- Targeting components of the PI3K/AKT/mTOR pathway holds promise for improving oral cancer therapy.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
08:07Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence
Published on: April 28, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...